Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma.

Neesse A, Krug S, Gress TM, Tuveson DA, Michl P.

Onco Targets Ther. 2013 Dec 18;7:33-43. doi: 10.2147/OTT.S38111. Review.

2.

Matrix control of pancreatic cancer: New insights into fibronectin signaling.

Topalovski M, Brekken RA.

Cancer Lett. 2016 Oct 10;381(1):252-8. doi: 10.1016/j.canlet.2015.12.027. Epub 2015 Dec 29.

PMID:
26742464
3.

Pancreatic cancer: Stroma and its current and emerging targeted therapies.

Kota J, Hancock J, Kwon J, Korc M.

Cancer Lett. 2017 Apr 10;391:38-49. doi: 10.1016/j.canlet.2016.12.035. Epub 2017 Jan 14.

PMID:
28093284
4.

Pancreatic cancer stroma: controversies and current insights.

Ansari D, Carvajo M, Bauden M, Andersson R.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):641-646. doi: 10.1080/00365521.2017.1293726. Epub 2017 Feb 24.

PMID:
28276831
5.

Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.

Nagathihalli NS, Castellanos JA, Shi C, Beesetty Y, Reyzer ML, Caprioli R, Chen X, Walsh AJ, Skala MC, Moses HL, Merchant NB.

Gastroenterology. 2015 Dec;149(7):1932-1943.e9. doi: 10.1053/j.gastro.2015.07.058. Epub 2015 Aug 7.

6.

The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance.

Erkan M, Reiser-Erkan C, Michalski CW, Kong B, Esposito I, Friess H, Kleeff J.

Curr Mol Med. 2012 Mar;12(3):288-303. Review.

PMID:
22272725
7.

Deciphering the role of stroma in pancreatic cancer.

Waghray M, Yalamanchili M, di Magliano MP, Simeone DM.

Curr Opin Gastroenterol. 2013 Sep;29(5):537-43. doi: 10.1097/MOG.0b013e328363affe. Review.

8.

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma.

Sato N, Cheng XB, Kohi S, Koga A, Hirata K.

Acta Pharm Sin B. 2016 Mar;6(2):101-5. doi: 10.1016/j.apsb.2016.01.002. Epub 2016 Jan 21. Review.

9.

Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Li X, Ma Q, Xu Q, Duan W, Lei J, Wu E.

Curr Pharm Des. 2012;18(17):2404-15. Review.

10.

The role of stromal cancer-associated fibroblasts in pancreatic cancer.

von Ahrens D, Bhagat TD, Nagrath D, Maitra A, Verma A.

J Hematol Oncol. 2017 Mar 28;10(1):76. doi: 10.1186/s13045-017-0448-5. Review.

11.

Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.

Rucki AA, Zheng L.

World J Gastroenterol. 2014 Mar 7;20(9):2237-46. doi: 10.3748/wjg.v20.i9.2237. Review.

12.

Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.

Sato N, Kohi S, Hirata K, Goggins M.

Cancer Sci. 2016 May;107(5):569-75. doi: 10.1111/cas.12913. Epub 2016 Mar 18. Review.

13.

A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.

Drifka CR, Eliceiri KW, Weber SM, Kao WJ.

Lab Chip. 2013 Oct 7;13(19):3965-75. doi: 10.1039/c3lc50487e.

14.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
15.

Therapeutic targeting of pancreatic stroma.

Liss AS, Thayer SP.

In: Grippo PJ, Munshi HG, editors. Pancreatic Cancer and Tumor Microenvironment. Trivandrum (India): Transworld Research Network; 2012. Chapter 9.

16.

Stroma and pancreatic ductal adenocarcinoma: an interaction loop.

Luo G, Long J, Zhang B, Liu C, Xu J, Ni Q, Yu X.

Biochim Biophys Acta. 2012 Aug;1826(1):170-8. doi: 10.1016/j.bbcan.2012.04.002. Epub 2012 Apr 13. Review.

PMID:
22521638
17.

Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression.

Felix K, Gaida MM.

Int J Biol Sci. 2016 Jan 28;12(3):302-13. doi: 10.7150/ijbs.14996. eCollection 2016. Review.

18.

Interaction of stellate cells with pancreatic carcinoma cells.

Habisch H, Zhou S, Siech M, Bachem MG.

Cancers (Basel). 2010 Sep 9;2(3):1661-82. doi: 10.3390/cancers2031661.

19.

Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.

Haqq J, Howells LM, Garcea G, Metcalfe MS, Steward WP, Dennison AR.

Eur J Cancer. 2014 Oct;50(15):2570-82. doi: 10.1016/j.ejca.2014.06.021. Epub 2014 Aug 1. Review.

PMID:
25091797
20.

Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises.

Mei L, Du W, Ma WW.

J Gastrointest Oncol. 2016 Jun;7(3):487-94. doi: 10.21037/jgo.2016.03.03. Review.

Supplemental Content

Support Center